Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ubiquitin-fold modifier 1 pseudogene is a DNA segment in the human genome (Ensembl: ENSG00000234061) that closely resembles the coding sequence of the functional ubiquitin-fold modifier 1 (UFM1) gene, but due to accumulated mutations, it cannot produce a functional protein. Pseudogenes are considered genomic relics and are largely non-functional, usually originating by gene duplication events or retrotransposition. Most pseudogenes, such as this one, do not participate in cell signaling, metabolic processes, or serve as drug targets, though a few may exert rare regulatory RNA functions in disease. There is no evidence that ENSG00000234061 is directly implicated in disease, acts as a biomarker, or interacts with known drugs. It should not be considered a receptor, enzyme, transporter, or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin-fold modifier 1 pseudogene.